Table of Content

1 Anti-Migraine Drugs Market Overview
1.1 Anti-Migraine Drugs Product Scope
1.2 Anti-Migraine Drugs Segment by Type
1.2.1 Global Anti-Migraine Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Triptans
1.2.3 Ergots
1.2.4 Others
1.3 Anti-Migraine Drugs Segment by Application
1.3.1 Global Anti-Migraine Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Women
1.3.3 Men
1.4 Anti-Migraine Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Anti-Migraine Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Anti-Migraine Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Anti-Migraine Drugs Price Trends (2016-2027)

2 Anti-Migraine Drugs Estimates and Forecasts by Region
2.1 Global Anti-Migraine Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Anti-Migraine Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Anti-Migraine Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Anti-Migraine Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Anti-Migraine Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Anti-Migraine Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Anti-Migraine Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Anti-Migraine Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Anti-Migraine Drugs Estimates and Projections (2016-2027)
2.4.3 China Anti-Migraine Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Anti-Migraine Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Anti-Migraine Drugs Estimates and Projections (2016-2027)
2.4.6 India Anti-Migraine Drugs Estimates and Projections (2016-2027)

3 Global Anti-Migraine Drugs Competition Landscape by Players
3.1 Global Top Anti-Migraine Drugs Players by Sales (2016-2021)
3.2 Global Top Anti-Migraine Drugs Players by Revenue (2016-2021)
3.3 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Migraine Drugs as of 2020)
3.4 Global Anti-Migraine Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Anti-Migraine Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Anti-Migraine Drugs Market Size by Type
4.1 Global Anti-Migraine Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Anti-Migraine Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Anti-Migraine Drugs Price by Type (2016-2021)
4.2 Global Anti-Migraine Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Anti-Migraine Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Anti-Migraine Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Anti-Migraine Drugs Price Forecast by Type (2022-2027)

5 Global Anti-Migraine Drugs Market Size by Application
5.1 Global Anti-Migraine Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Anti-Migraine Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Anti-Migraine Drugs Price by Application (2016-2021)
5.2 Global Anti-Migraine Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Anti-Migraine Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Anti-Migraine Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Anti-Migraine Drugs Price Forecast by Application (2022-2027)

6 North America Anti-Migraine Drugs Market Facts & Figures
6.1 North America Anti-Migraine Drugs Sales by Company
6.1.1 North America Anti-Migraine Drugs Sales by Company (2016-2021)
6.1.2 North America Anti-Migraine Drugs Revenue by Company (2016-2021)
6.2 North America Anti-Migraine Drugs Sales Breakdown by Type
6.2.1 North America Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Anti-Migraine Drugs Sales Breakdown by Application
6.3.1 North America Anti-Migraine Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Anti-Migraine Drugs Sales Breakdown by Application (2022-2027)

7 Europe Anti-Migraine Drugs Market Facts & Figures
7.1 Europe Anti-Migraine Drugs Sales by Company
7.1.1 Europe Anti-Migraine Drugs Sales by Company (2016-2021)
7.1.2 Europe Anti-Migraine Drugs Revenue by Company (2016-2021)
7.2 Europe Anti-Migraine Drugs Sales Breakdown by Type
7.2.1 Europe Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Anti-Migraine Drugs Sales Breakdown by Application
7.3.1 Europe 131 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 131 Sales Breakdown by Application (2022-2027)

8 China Anti-Migraine Drugs Market Facts & Figures
8.1 China Anti-Migraine Drugs Sales by Company
8.1.1 China Anti-Migraine Drugs Sales by Company (2016-2021)
8.1.2 China Anti-Migraine Drugs Revenue by Company (2016-2021)
8.2 China Anti-Migraine Drugs Sales Breakdown by Type
8.2.1 China Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
8.3 China Anti-Migraine Drugs Sales Breakdown by Application
8.3.1 China 157 Sales Breakdown by Application (2016-2021)
8.3.2 China 157 Sales Breakdown by Application (2022-2027)

9 Japan Anti-Migraine Drugs Market Facts & Figures
9.1 Japan Anti-Migraine Drugs Sales by Company
9.1.1 Japan Anti-Migraine Drugs Sales by Company (2016-2021)
9.1.2 Japan Anti-Migraine Drugs Revenue by Company (2016-2021)
9.2 Japan Anti-Migraine Drugs Sales Breakdown by Type
9.2.1 Japan Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Anti-Migraine Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Anti-Migraine Drugs Market Facts & Figures
10.1 Southeast Asia Anti-Migraine Drugs Sales by Company
10.1.1 Southeast Asia Anti-Migraine Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Anti-Migraine Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Anti-Migraine Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Anti-Migraine Drugs Market Facts & Figures
11.1 India Anti-Migraine Drugs Sales by Company
11.1.1 India Anti-Migraine Drugs Sales by Company (2016-2021)
11.1.2 India Anti-Migraine Drugs Revenue by Company (2016-2021)
11.2 India Anti-Migraine Drugs Sales Breakdown by Type
11.2.1 India Anti-Migraine Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Anti-Migraine Drugs Sales Breakdown by Type (2022-2027)
11.3 India Anti-Migraine Drugs Sales Breakdown by Application
11.3.1 India Anti-Migraine Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Anti-Migraine Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Anti-Migraine Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Business Overview
12.1.3 Eli Lilly Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Abbott
12.2.1 Abbott Corporation Information
12.2.2 Abbott Business Overview
12.2.3 Abbott Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Abbott Anti-Migraine Drugs Products Offered
12.2.5 Abbott Recent Development
12.3 Eisai
12.3.1 Eisai Corporation Information
12.3.2 Eisai Business Overview
12.3.3 Eisai Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eisai Anti-Migraine Drugs Products Offered
12.3.5 Eisai Recent Development
12.4 Allergan
12.4.1 Allergan Corporation Information
12.4.2 Allergan Business Overview
12.4.3 Allergan Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Allergan Anti-Migraine Drugs Products Offered
12.4.5 Allergan Recent Development
12.5 Endo
12.5.1 Endo Corporation Information
12.5.2 Endo Business Overview
12.5.3 Endo Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Endo Anti-Migraine Drugs Products Offered
12.5.5 Endo Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GlaxoSmithKline Anti-Migraine Drugs Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 Impax Laboratories
12.7.1 Impax Laboratories Corporation Information
12.7.2 Impax Laboratories Business Overview
12.7.3 Impax Laboratories Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Impax Laboratories Anti-Migraine Drugs Products Offered
12.7.5 Impax Laboratories Recent Development
12.8 Pfizer
12.8.1 Pfizer Corporation Information
12.8.2 Pfizer Business Overview
12.8.3 Pfizer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Pfizer Anti-Migraine Drugs Products Offered
12.8.5 Pfizer Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Corporation Information
12.9.2 AstraZeneca Business Overview
12.9.3 AstraZeneca Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 AstraZeneca Anti-Migraine Drugs Products Offered
12.9.5 AstraZeneca Recent Development
12.10 Bayer
12.10.1 Bayer Corporation Information
12.10.2 Bayer Business Overview
12.10.3 Bayer Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Bayer Anti-Migraine Drugs Products Offered
12.10.5 Bayer Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Corporation Information
12.11.2 Johnson & Johnson Business Overview
12.11.3 Johnson & Johnson Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Johnson & Johnson Anti-Migraine Drugs Products Offered
12.11.5 Johnson & Johnson Recent Development
12.12 Merck
12.12.1 Merck Corporation Information
12.12.2 Merck Business Overview
12.12.3 Merck Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Merck Anti-Migraine Drugs Products Offered
12.12.5 Merck Recent Development
12.13 Teva
12.13.1 Teva Corporation Information
12.13.2 Teva Business Overview
12.13.3 Teva Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Teva Anti-Migraine Drugs Products Offered
12.13.5 Teva Recent Development
12.14 Amgen
12.14.1 Amgen Corporation Information
12.14.2 Amgen Business Overview
12.14.3 Amgen Anti-Migraine Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Amgen Anti-Migraine Drugs Products Offered
12.14.5 Amgen Recent Development

13 Anti-Migraine Drugs Manufacturing Cost Analysis
13.1 Anti-Migraine Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Migraine Drugs
13.4 Anti-Migraine Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Migraine Drugs Distributors List
14.3 Anti-Migraine Drugs Customers

15 Market Dynamics
15.1 Anti-Migraine Drugs Market Trends
15.2 Anti-Migraine Drugs Drivers
15.3 Anti-Migraine Drugs Market Challenges
15.4 Anti-Migraine Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-Migraine Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Anti-Migraine Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Anti-Migraine Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Anti-Migraine Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Anti-Migraine Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Anti-Migraine Drugs Revenue Share by Region (2016-2021)
Table 8. Global Anti-Migraine Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Anti-Migraine Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Anti-Migraine Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Anti-Migraine Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Anti-Migraine Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Anti-Migraine Drugs Sales Share by Company (2016-2021)
Table 14. Global Anti-Migraine Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Anti-Migraine Drugs Revenue Share by Company (2016-2021)
Table 16. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Migraine Drugs as of 2020)
Table 17. Global Anti-Migraine Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Anti-Migraine Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-Migraine Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Anti-Migraine Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Anti-Migraine Drugs Sales Share by Type (2016-2021)
Table 23. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Anti-Migraine Drugs Sales Share by Type (2022-2027)
Table 26. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Anti-Migraine Drugs Revenue Share by Type (2022-2027)
Table 28. Global Anti-Migraine Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Anti-Migraine Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Anti-Migraine Drugs Sales Share by Application (2016-2021)
Table 31. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Anti-Migraine Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Anti-Migraine Drugs Sales Share by Application (2022-2027)
Table 35. Global Anti-Migraine Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Anti-Migraine Drugs Revenue Share by Application (2022-2027)
Table 37. Global Anti-Migraine Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Anti-Migraine Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Anti-Migraine Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Anti-Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Anti-Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Anti-Migraine Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Anti-Migraine Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Anti-Migraine Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Anti-Migraine Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Anti-Migraine Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Anti-Migraine Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Anti-Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Anti-Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Anti-Migraine Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Anti-Migraine Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Anti-Migraine Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Anti-Migraine Drugs Sales Market Share by Application (2022-2027)
Table 62. China Anti-Migraine Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Anti-Migraine Drugs Sales Market Share by Company (2016-2021)
Table 64. China Anti-Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Anti-Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 68. China Anti-Migraine Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Anti-Migraine Drugs Sales Market Share by Type (2022-2027)
Table 70. China Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 72. China Anti-Migraine Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Anti-Migraine Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Anti-Migraine Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Anti-Migraine Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Anti-Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Anti-Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Anti-Migraine Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Anti-Migraine Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Anti-Migraine Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Anti-Migraine Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Anti-Migraine Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Anti-Migraine Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Anti-Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Anti-Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Anti-Migraine Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Anti-Migraine Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Anti-Migraine Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Anti-Migraine Drugs Sales Market Share by Application (2022-2027)
Table 98. India Anti-Migraine Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Anti-Migraine Drugs Sales Market Share by Company (2016-2021)
Table 100. India Anti-Migraine Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Anti-Migraine Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Anti-Migraine Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Anti-Migraine Drugs Sales Market Share by Type (2016-2021)
Table 104. India Anti-Migraine Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Anti-Migraine Drugs Sales Market Share by Type (2022-2027)
Table 106. India Anti-Migraine Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Anti-Migraine Drugs Sales Market Share by Application (2016-2021)
Table 108. India Anti-Migraine Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Anti-Migraine Drugs Sales Market Share by Application (2022-2027)
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Eli Lilly Anti-Migraine Drugs Product
Table 114. Eli Lilly Recent Development
Table 115. Abbott Corporation Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Abbott Anti-Migraine Drugs Product
Table 119. Abbott Recent Development
Table 120. Eisai Corporation Information
Table 121. Eisai Description and Business Overview
Table 122. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Eisai Anti-Migraine Drugs Product
Table 124. Eisai Recent Development
Table 125. Allergan Corporation Information
Table 126. Allergan Description and Business Overview
Table 127. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Allergan Anti-Migraine Drugs Product
Table 129. Allergan Recent Development
Table 130. Endo Corporation Information
Table 131. Endo Description and Business Overview
Table 132. Endo Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Endo Anti-Migraine Drugs Product
Table 134. Endo Recent Development
Table 135. GlaxoSmithKline Corporation Information
Table 136. GlaxoSmithKline Description and Business Overview
Table 137. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. GlaxoSmithKline Anti-Migraine Drugs Product
Table 139. GlaxoSmithKline Recent Development
Table 140. Impax Laboratories Corporation Information
Table 141. Impax Laboratories Description and Business Overview
Table 142. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Impax Laboratories Anti-Migraine Drugs Product
Table 144. Impax Laboratories Recent Development
Table 145. Pfizer Corporation Information
Table 146. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Pfizer Description and Business Overview
Table 148. Pfizer Anti-Migraine Drugs Product
Table 149. Pfizer Recent Development
Table 150. AstraZeneca Corporation Information
Table 151. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. AstraZeneca Description and Business Overview
Table 153. AstraZeneca Anti-Migraine Drugs Product
Table 154. AstraZeneca Recent Development
Table 155. Bayer Corporation Information
Table 156. Bayer Description and Business Overview
Table 157. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Bayer Anti-Migraine Drugs Product
Table 159. Bayer Recent Development
Table 160. Johnson & Johnson Corporation Information
Table 161. Johnson & Johnson Description and Business Overview
Table 162. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Johnson & Johnson Anti-Migraine Drugs Product
Table 164. Johnson & Johnson Recent Development
Table 165. Merck Corporation Information
Table 166. Merck Description and Business Overview
Table 167. Merck Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Merck Anti-Migraine Drugs Product
Table 169. Merck Recent Development
Table 170. Teva Corporation Information
Table 171. Teva Description and Business Overview
Table 172. Teva Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Teva Anti-Migraine Drugs Product
Table 174. Teva Recent Development
Table 175. Amgen Corporation Information
Table 176. Amgen Description and Business Overview
Table 177. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Amgen Anti-Migraine Drugs Product
Table 179. Amgen Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Anti-Migraine Drugs Distributors List
Table 183. Anti-Migraine Drugs Customers List
Table 184. Anti-Migraine Drugs Market Trends
Table 185. Anti-Migraine Drugs Market Drivers
Table 186. Anti-Migraine Drugs Market Challenges
Table 187. Anti-Migraine Drugs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Migraine Drugs Product Picture
Figure 2. Global Anti-Migraine Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Triptans Product Picture
Figure 4. Ergots Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anti-Migraine Drugs Sales Market Share by Application in 2021 & 2027
Figure 7. Women Examples
Figure 8. Men Examples
Figure 9. Global Anti-Migraine Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Anti-Migraine Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Anti-Migraine Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Anti-Migraine Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 13. Global Anti-Migraine Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Anti-Migraine Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Anti-Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Anti-Migraine Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Anti-Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Anti-Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Anti-Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Anti-Migraine Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Anti-Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Anti-Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Anti-Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Anti-Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Anti-Migraine Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Anti-Migraine Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Anti-Migraine Drugs Players Market Share by Revenue in Anti-Migraine Drugs: 2016 & 2020
Figure 28. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Anti-Migraine Drugs Revenue Share by Type (2016-2021)
Figure 30. Global Anti-Migraine Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Anti-Migraine Drugs Revenue Share by Application (2016-2021)
Figure 32. Global Anti-Migraine Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 34. North America Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 35. Europe Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 36. Europe Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 37. China Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 38. China Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 39. Japan Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 40. Japan Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 41. Southeast Asia Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 42. Southeast Asia Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 43. India Anti-Migraine Drugs Sales Market Share by Type in 2020
Figure 44. India Anti-Migraine Drugs Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Anti-Migraine Drugs
Figure 47. Manufacturing Process Analysis of Anti-Migraine Drugs
Figure 48. Anti-Migraine Drugs Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed